Skip to content
DISCOVER THE MOST SUITABLE TESTS FOR YOU
DISCOVER THE MOST SUITABLE TESTS FOR YOU
Image of a sedentary teenager with toxic habits

Adult Treatment Panel III (ATP-III): detection of metabolic syndrome

Written by: Adrià Roca

|

Published on

|

Time to read 3 min

What is ATP-III?

The Adult Treatment Panel III (ATP-III) is a set of criteria developed by the National Cholesterol Education Program (NCEP) for diagnosing metabolic syndrome (MetS). Accordingto ATP-III, a diagnosis of metabolic syndrome can be made if three or more of thefollowing conditions are present:

    • Abdominal obesity (waist circumference > 102 cm in men and > 88 cm in women)
    • Hypertriglyceridemia (triglycerides > 150 mg/dL)
    • Low HDL cholesterol (< 40 mg/dL in men; < 50 mg/dL in women)
    • Hypertension (> 130/85 mmHg)
    • Elevated fasting glucose (glucose > 110 mg/dL)

What is metabolic syndrome?

Metabolic syndrome is a cluster of conditions that collectively increase the risk of heart disease, type 2 diabetes mellitus, and other health problems, which can become severe if not addressed promptly. Specifically, metabolic syndrome encompasses a range of physiological, biochemical, clinical, and metabolic factors that significantly heighten therisk of cardiovascular disease, type 2 diabetes mellitus, certain cancers, and mortalityfrom these conditions.

How is metabolic syndrome diagnosed?

The ATP-III criteria allow for the early detection of patients with metabolic syndrome,enabling them to take corrective measures as soon as possible.


Moreover, ATP-III helps identify individuals at higher risk for developing cardiovascular diseases (CVD) or endocrine pancreatic dysfunction, such as insulin resistance (IR), prediabetes, and type 2 diabetes mellitus (DM2). It also identifies patients at increased risk of liver or kidney diseases.However, ATP-III does not distinguish patients with insulin resistance from those who fallunder the broader category of metabolic syndrome. As a result, additional testing isnecessary to determine whether these individuals have insulin resistance or diabetes inaddition to metabolic syndrome.


ATP-III also outlines several non-pharmacological treatments to reverse metabolic syndrome. These measures focus on lifestyle and dietary changes, including:

    • Heart-healthy eating plan: A diet that limits saturated and trans fats whileemphasizing a variety of nutrient-rich foods, such as fruits, vegetables, wholegrains, and lean proteins.
    • Achieving a healthy weight.
    • Stress management.
    • Engaging in regular physical activity.
    • Quitting Smoking.
    • These strategies are essential for mitigating the risks associated with metabolicsyndrome and improving long-term health outcomes.

Related diagnostic tests

Can the metabolic syndrome be prevented?

The best way of preventing metabolic syndrome is through changes in a healthy lifestylefor the heart.


We also recommend consulting a healthcare professional regarding the differentprevention programs. These include: primary prevention, aimed at reducing theincidence of a disease by implementing measures designed to prevent its onset (such asvaccination programs or awareness campaigns and counseling to encourage changes inhigh-risk behaviors); secondary prevention, aimed at reducing the prevalence of diseaseby implementing measures to stop or slow the progression of a condition already presentat any stage of its development (such as various screening or early detection programs);and tertiary prevention, aimed at avoiding complications or significant harm byimplementing measures to control its progression (such as regular monitoring of chronicpatients, for example).

Related prevention tests

Summary

The Adult Treatment Panel III (ATP-III) is a set of criteria developed by the National Cholesterol Education Program (NCEP) for diagnosing metabolic syndrome (MetS).

Metabolic syndrome is a cluster of conditions that collectively increase the risk of heart disease, type 2 diabetes mellitus (DM2), and other health problems, which can become severe if not addressed promptly.

The ATP-III criteria allow for the early detection of patients with metabolic syndrome,enabling them to take corrective measures as soon as possible.

Author

Picture of Adrià Roca

Adrià Roca

Graduate in Biochemistry with a Master's degree in Biochemistry, Molecular Biology and Biomedicine, with a specialization in Biomolecules in Biomedical Research. Previous experience as a Laboratory Technician at Althaia (Hospital Sant Joan de Déu, Manresa). Master's Thesis developed at the Biophysics Unit (Universitat Autònoma de Barcelona), the ALBA synchrotron and at the Research Centre of l'Hospital de la Santa Creu i Sant Pau. Currently working as Director of Science and Regulatory Affairs at Blueberry Diagnostics.

Share this post

Other related posts